12 completed, 1 recruiting, 1 unknown. 14 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 14 | Completed 12, Recruiting 1, Unknown 1 |
| Phase 2 | 4 | Completed 4 |
Follow Risk-Taking: new trials by email Literature Review of Risk-Taking trials Research Report on Risk-Taking
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Frontal iTBS for Impulsivity and Suicidal Ideation in Veterans With Mild Traumatic Brain Injury intermittent theta burst stimulation, placebo intermittent theta burst stimulation - Mild Traumatic Brain Injury, Suicidal Ideation | Phase 1 | Recruiting | VA Office of Research and Development | 55 | 2024-05-20 | 2026-04-14 |
| Effect of Acute Alcohol Intoxication on Neural Processes During Decisions to Engage in HIV Risk Behaviors Alcohol beverage, Placebo beverage - Alcohol Consumption | Phase 1 | Completed | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 20 | 2021-03-18 | 2026-10-26 |
| The Effect of Regular Naltrexone Dosing on Disordered Gamblers Naltrexone - Gambling | Phase 1 | Completed | University of Calgary | 35 | 2016-04-01 | 2022-06-01 |
| XY-Zone Program Evaluation: A School-Based Dropout Prevention Program for At-Risk Youth XY-Zone - Adolescent Problem Behavior at School, Risk Behavior | Phase 1 / Phase 2 | Completed | University of Texas at Austin | 91 | 2011-08-01 | 2013-07-10 |
| Deep Low-Frequency Repetitive Transcranial Magnetic Stimulation for Cessation of Pathological Gambling Real Deep TMS, Sham Deep TMS - Pathological Gambling | Phase 1 | Unknown | BeerYaakov Mental Health Center | 40 | 2010-06-01 | 2010-07-14 |
| Effects of Smoked Marijuana on Risk Taking and Decision Making Tasks Inactive Marijuana (0% THC), Low THC marijuana (1.8 %THC), High THC marijuana (3.9% THC) - Marijuana Use Disorder | Phase 1 | Completed | New York State Psychiatric Institute | 36 | 2006-05-01 | 2018-12-19 |
| Evaluation of the Healthy Love Workshop, an HIV Prevention Intervention for African American Women Healthy Love Workshop, HIV/AIDS 101 Workshop - HIV Infections, Sexually Transmitted Infections | Phase 1 / Phase 2 | Completed | Centers for Disease Control and Prevention | 313 | 2006-05-01 | 2010-05-14 |
| An Open-Label Study of N-Acetyl Cysteine in Pathological Gambling N-Acetyl Cysteine - Pathological Gambling | Phase 1 | Completed | University of Minnesota | 36 | 2006-01-01 | 2007-04-30 |
| Evaluation of Many Men, Many Voices, An STD/HIV Prevention Intervention for Black MSM Many Men, Many Voices (3MV) - HIV Infections, Sexually Transmitted Diseases | Phase 1 / Phase 2 | Completed | Centers for Disease Control and Prevention | 341 | 2005-08-01 | 2010-06-24 |
| Evaluation of the Preventing AIDS Through Live Movement and Sound (PALMS) Intervention for Minority Adolescents Preventing AIDS Through Live Movement and Sound (PALMS) - Hiv | Phase 1 / Phase 2 | Completed | Centers for Disease Control and Prevention | 264 | 2005-03-01 | 2026-05-11 |
| Cognitive Motivational Behavior Therapy for Gamblers Cognitive Motivational Behavior Therapy - Gambling | Phase 1 | Completed | University at Albany | 40 | 2003-09-01 | 2014-01-01 |
| Cognitive-Behavioral Treatment of Gambling Cognitive behavior therapy, Contingency management - Gambling, Mental Health | Phase 1 | Completed | UConn Health | 120 | 2002-11-01 | 2013-07-01 |
| Cognitive Behavioral Therapy for Treatment of Pathological Gambling Referral to Gamblers Anonymous, Cognitive behavioral therapy, Cognitive behavioral self-help manual - Gambling | Phase 1 | Completed | UConn Health | 231 | 1998-03-01 | 2013-07-01 |
| Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative Adults ALVAC(2)120(B,MN)GNP (vCP1452), gp160 MN/LAI-2, ALVAC(1)120(B,MN)GNP (vCP1433) - HIV Infections | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 100 | 2021-11-04 |
Gambling (6) · HIV Infections (3) · Safe Sex (3) · Sexual Behavior (3) · Sexually Transmitted Diseases (2) · Acquired Immunodeficiency Syndrome (1) · Alcohol Drinking (1) · Alcoholic Intoxication (1) · Behavior, Addictive (1) · Binge-Eating Disorder (1) · Brain Concussion (1) · Brain Diseases (1) · Brain Injuries (1) · Brain Injuries, Traumatic (1)
Behavior (14) · Mental Disorders (7) · Disruptive, Impulse Control, and Conduct Disorders (6) · Blood-Borne Infections (4) · Communicable Diseases (4) · Genital Diseases (4) · Immune System Diseases (4) · Immunologic Deficiency Syndromes (4) · Infections (4) · Lentivirus Infections (4) · RNA Virus Infections (4) · Retroviridae Infections (4) · Sexually Transmitted Diseases, Viral (4) · Urogenital Diseases (4)
Cognitive Behavioral Therapy (2) · Acetylcysteine (1) · Dronabinol (1) · Ethanol (1) · Naltrexone (1) · Sound (1) · nabiximols (1)
Centers for Disease Control and Prevention (3) · UConn Health (2) · BeerYaakov Mental Health Center (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · National Institute on Alcohol Abuse and Alcoholism (NIAAA) (1) · New York State Psychiatric Institute (1) · University at Albany (1) · University of Calgary (1) · University of Minnesota (1) · University of Texas at Austin (1) · VA Office of Research and Development (1)
United States (12) · Canada (1) · Israel (1)
Jeffrey H Herbst, PhD (3) · Thomas M Painter, PhD (3) · Nancy M. Petry, PhD (2) · Alexandra L Aaronson, MD (1) · Clayton Harro (1) · Darren R Christensen, PhD (1) · David Schwartz (1) · David W Springer, PhD (1) · Dazon Dixon Diallo, MPH (1) · Efrat Aharonovich, Ph.D. (1) · Jennifer Lauby, PhD (1) · Jon E Grant, MD, JD (1) · Katherine L Montgomery, PhD, MSSW (1) · Margaret Haney, Ph.D. (1) · Melanie L Schwandt, Ph.D. (1)
PMID 19267264, PMID 20135214, PMID 24743662, PMID 24743663, PMID 39671573
R01MH060417 (2), R21MH064568 (1)